Literature DB >> 8393085

Endogenous noradrenaline activates alpha 2-adrenoceptors on serotonergic nerve endings in human and rat neocortex.

T J Feuerstein1, A Mutschler, A Lupp, V Van Velthoven, E Schlicker, M Göthert.   

Abstract

Slices from human neocortex preincubated with [3H]serotonin ([3H]5-HT) were superfused and stimulated electrically to investigate whether the alpha 2-adrenoceptors on serotonergic terminals can be stimulated by endogenous noradrenaline (NA) released from neighboring noradrenergic fibers. The stimulation-evoked 3H overflow, representing action potential-induced, exocytotic release of 5-HT, was depressed by the NA uptake blocker (+)-oxaprotiline. Rauwolscine (a mixed alpha 2-adrenoceptor antagonist/5-HT autoreceptor agonist) or phentolamine [a combined alpha-adrenoceptor/5-HT autoreceptor antagonist; the latter drug in the presence of (+)-oxaprotiline] enhanced the release when the 5-HT autoreceptors had previously been blocked by metitepine. Under hypothermia the release of 5-HT was found to be decreased and that of NA to be increased; under these conditions idazoxan (an alpha 2-adrenoceptor antagonist) enhanced the release of 5-HT. In neocortex slices from rats (+)-oxaprotiline similarly depressed the release of 5-HT (measured with the same methods) as in human tissue. When rats were pretreated with 6-hydroxydopamine, the inhibitory effect of exogenous NA on 5-HT release was increased, and in slices from rats pretreated with desipramine, it was decreased. In conclusion, alpha 2-heteroreceptors can be activated by endogenous NA released from neighboring noradrenergic fibers. Because regulatory processes analogous to those in rats probably occur in humans as well, an up- or down-regulation of alpha 2-heteroreceptors in depressed patients with a (pathological) decrease or a (therapeutic) enhancement of the noradrenergic neurotransmission may also be assumed to occur.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393085     DOI: 10.1111/j.1471-4159.1993.tb02148.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Opioid receptor-mediated control of acetylcholine release in human neocortex tissue.

Authors:  T J Feuerstein; O Gleichauf; D Peckys; G B Landwehrmeyer; R Scheremet; R Jackisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.

Authors:  Benjamin Berger; Anna Katharina Rothmaier; Franziska Wedekind; Josef Zentner; Thomas J Feuerstein; Rolf Jackisch
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

3.  Presynaptic inhibitory serotonin autoreceptors in the human hippocampus.

Authors:  E Schlicker; K Fink; J Zentner; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  The yohimbine-induced anticonflict effect in the rat, Part II. Neurochemical findings.

Authors:  A Söderpalm; F Ehrenström; B Söderpalm
Journal:  J Neural Transm Gen Sect       Date:  1995

5.  The N251K functional polymorphism in the alpha(2A)-adrenoceptor gene is not associated with depression: a study in suicide completers.

Authors:  Idoia Martín-Guerrero; Luis F Callado; Koldo Saitua; Guadalupe Rivero; Africa García-Orad; J Javier Meana
Journal:  Psychopharmacology (Berl)       Date:  2005-12-07       Impact factor: 4.530

6.  Cortical hypometabolism in injured brain: new correlations with the noradrenergic and serotonergic systems and with behavioral deficits.

Authors:  H M Pappius
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

7.  Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice.

Authors:  J Scheibner; A U Trendelenburg; L Hein; K Starke
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

8.  A re-evaluation of the role of alpha 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat.

Authors:  W S Redfern; A Williams
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  Effects of 5-HT receptor agonists on depolarization-induced [3H]-noradrenaline release in rabbit hippocampus and human neocortex.

Authors:  C Allgaier; P Warnke; A P Stangl; T J Feuerstein
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.

Authors:  P Blier; C Bouchard
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.